Big Pharma Wants to Use AI to Increase Diversity in Clinical Trials

“AI could do that, but I could do it, too, as long as I were allowed to pay for people’s parking—as long as I did it in resourced wealthy places,” says Brawley, who previously worked at Grady Memorial Hospital in Atlanta, where, he says, he didn’t have resources to run clinical trials. Even at Johns Hopkins, he loses minorities more so than Whites because of parking costs, he says.

Leave a Comment